Clinical Trials: A Phase I Efficacy and Safety Study of HPV16-specific Therapeutic DNA-vaccinia Vaccination in Combination With Topical Imiquimod, in Patients With HPV16+ High Grade Cervical Dysplasia (CIN3)
Sponsor and Collaborators
Johns Hopkins University
National Cancer Institute (NCI)
Contact
Clinical Trials Office, Sidney Kimmel Comprehensive Cancer Center
410-955-8804
Principal Investigator
Cornelia L. Trimble, MD Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier
NCT00788164
